Log in
Enquire now
‌

US Patent 11351266 Conjugate of isotretinoin and peptide

Patent 11351266 was granted and assigned to Caregen Co., Ltd. on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Caregen Co., Ltd.
Caregen Co., Ltd.
0
Current Assignee
Caregen Co., Ltd.
Caregen Co., Ltd.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113512660
Patent Inventor Names
Yong Ji Chung0
Eun Mi Kim0
Date of Patent
June 7, 2022
0
Patent Application Number
166121250
Date Filed
May 11, 2018
0
Patent Primary Examiner
‌
Julie Ha
0
CPC Code
‌
A61K 2800/522
0
‌
A61Q 17/00
0
‌
A61Q 19/00
0
‌
A61K 8/64
0
‌
C07K 7/08
0
‌
A61K 47/64
0
‌
A61K 31/19
0
‌
C07K 19/00
0
...

A compound comprising a structure in which isotretinoin is linked to a peptide via a covalent bond and an antibiotic, anti-inflammatory, or anti-oxidative pharmaceutical or cosmetic composition comprising the same. A compound having a structure in which isotretinoin is linked to a peptide via a covalent bond according to the present invention exhibits excellent physiological activity such as antibiotic, anti-inflammatory, or anti-oxidative actions, as well as having outstanding properties, such as solubility in water, etc., and thus can find useful applications in various fields including medicines, cosmetics, etc.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11351266 Conjugate of isotretinoin and peptide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.